RedShift BioAnalytics Announces Distribution Agreement with Flownamics for The Director™ Liquid Handler.

The recently launched HaLCon Analyzer from RedShiftBio and the Flownamics Director are perfectly suited to jointly deliver HPLC-quality protein titer for bioprocessing with even greater efficiency and throughput. BOXBOROUGH, Mass. -- RedShift BioAnalytics (RedShiftBio®) today announced that it has signed a global distribution agreement with Flownamics for the Director™ Sample Distribution System. The Director™ from Flownamics [...]

Element Biosciences Adds Genomics Executive to Leadership Team to Accelerate Corporate Development

Yaron Hakak brings over 20 years of experience in new products, technologies, and commercial partnerships SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the appointment of veteran life science executive Yaron Hakak as Senior Vice President of Corporate and [...]

Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies

Synthego to develop multiplexed and complex genetic engineering strategies, increasing the safety and speed at which bit.bio can engineer human cells for cell therapies. bit.bio aims to leverage technology to increase efficiency of human cell engineering and accelerate the development of highly scalable cell therapies that are capable of treating millions of patients. Redwood City, [...]

Oxford Nanopore announces education collaboration with Cold Spring Harbor DNA Learning Center and launches pilot accessible sequencing education programme

Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of “Education beta”, its pilot education programme and the first of its kind in the world delivering nanopore sequencing into the global education sector, with the aim to increase life science literacy for the next generation. The pilot will include up to 50 scientists wishing to [...]

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

LAKEWOOD, Colo. -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate and disclose scope 1 and 2 greenhouse gas emissions prior to the August 2024 Annual Meeting of Shareholders as part [...]

Oxford Nanopore announces education collaboration with Cold Spring Harbor DNA Learning Center and launches pilot accessible sequencing education programme

Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of “Education beta”, its pilot education programme and the first of its kind in the world delivering nanopore sequencing into the global education sector, with the aim to increase life science literacy for the next generation. The pilot will include up to 50 scientists wishing to [...]

Collaboration to improve process analytical technologies and AAV manufacturing for gene therapies

Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn announce collaboration  The collaborators will use automated and digital technologies to improve the process of manufacturing adeno-associated viruses (AAV) Stevenage and London, UK, and Laupheim, Germany– Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a [...]

OpenText Buys KineMatik

KineMatik provides automated Business Process and Project Management Solutions integrated with OpenText's Content Cloud business Waterloo, ON – OpenText™ (NASDAQ: OTEX), (TSX: OTEX) today announced the addition of automated Business Process and Project Management Solutions to the OpenText Content business through the acquisition of KineMatik. Based in Cork, Ireland, KineMatik provides workflow automation, Document Change Control, Project Management [...]

Xcell Biosciences and Labcorp Achieve Key Data Milestones in Cell and Gene Therapy Collaboration

Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration [...]

Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science

SEATTLE --  Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, proudly announces two recent SBIR grants worth $4.4 million from the National Institutes of Health (NIH) to support its pioneering work on implementing human models to advance discovery of the next generation of medicines. The first project will support [...]

Access IBO on Knowledge Center